Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step Guide

Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) improves short- and long-term urinary outcomes and overall quality of life significantly compared with standard robot-assisted radical prostatectomy (S-RARP). Positive surgical margin rates did not differ between RS-RARP and S-RARP, and RS-RARP had lower rates of nonfocal surgical margins. RS-RARP was not associated with an increased risk of biochemical recurrence on multivariate analysis; however, long-term study is needed to ensure oncologic efficacy.